- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD9773
Total 96 results
-
AstraZenecaCompletedSeptic Shock | Severe SepsisCzech Republic, France, Spain, Finland, Canada, Australia, Belgium
-
AstraZenecaCompletedSeptic Shock | Severe SepsisJapan
-
AstraZenecaQuintiles, Inc.Completed
-
AstraZenecaWithdrawnHealthy Male Subjects | Pharmacokinetics | Safety | Food EffectUnited Kingdom
-
AstraZenecaQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaParexelCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
AstraZenecaCompletedRenal ImpairmentUnited States
-
AstraZenecaCompletedAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | High Risk Myelodysplastic Syndrome | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma | Richter's Syndrome | T-cell Non-Hodgkin Lymphoma | Relapsed or Refractory...United Kingdom, Germany, Netherlands
-
AstraZenecaCompletedHepatic ImpairmentUnited States, Bulgaria, Slovakia
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaRecruitingInflammatory DiseasesUnited Kingdom
-
AstraZenecaNot yet recruitingHealthy ParticipantsUnited States
-
AstraZenecaWithdrawn
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthy Subjects | Pharmacokinetics | Tolerability | SafetyUnited Kingdom
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
AstraZenecaCompletedHER2-negative Breast CancerMexico, United Kingdom, Georgia
-
AstraZenecaParexelCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedHealthy | Elderly | TolerabilityUnited States
-
NYU Langone HealthTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | MyelofibrosesUnited States
-
AstraZenecaParexelCompletedHealthy VolunteersUnited States
-
AstraZenecaParexelCompleted
-
AstraZenecaQuotient SciencesCompletedER-positive, HER2-negative Breast CancerUnited Kingdom
-
AstraZenecaCompletedOvarian Cancer | Locally Advanced Solid Tumours | Metastatic Solid TumoursUnited States
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited Kingdom, United States
-
AstraZenecaTerminatedPreviously Treated Non Small Cell Lung CancerUnited States
-
AstraZenecaParexelCompletedUterine Serous CarcinomaUnited States, Italy, Spain, France, Canada
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterTerminated
-
Dana-Farber Cancer InstituteAstraZenecaActive, not recruitingUterine CancerUnited States
-
AstraZenecaQuintiles, Inc.CompletedSolid TumoursFrance, United Kingdom, Netherlands
-
AstraZenecaTerminatedPreviously Untreated Stage IV Non-Squamous Non Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)Completed
-
AstraZenecaCompletedHealthy Subjects | PharmacodynamicsUnited Kingdom
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
St. Joseph's Hospital and Medical Center, PhoenixBarbara Ann Karmanos Cancer Institute; American Society of Clinical Oncology; Translational Genomics Research Institute and other collaboratorsCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Locally Advanced Malignant Solid Neoplasm | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Locally Advanced Clear Cell Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid NeoplasmUnited States
-
University of BirminghamAstraZeneca; Cancer Research UKCompletedLarynx Cancer | Oral Cavity Squamous Cell Carcinoma | Hypopharynx Squamous Cell CarcinomaUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid TumoursJapan
-
Dana-Farber Cancer InstituteAstraZenecaCompleted
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada